Skip to main content

The Enhancing Oncology Care Model (EOM)


Request a proposal

 

Ensuring Success in the Enhancing Care Model

Carevive is here to ensure success in CMS’ value-based program, the Enhancing Oncology Model (EOM). Our technology was developed in collaboration with cancer experts and early adopters of oncology risk-based contracts, including CMS’ Oncology Care Model. Carevive technology, coupled with our professional services, enables EOM-required practice redesign that is feasible and scalable, and improves clinical outcomes below target costs.

A Holistic Cancer Care Management Technology Supporting EOM Practice Re-Design

Our cancer care management technology supports your cancer care team across the continuum of patient care.

Our cancer care management technology supports your cancer care team across the continuum of patient care.

Client Success Services for Implementation/Ongoing Support

Carevive’s client success professionals support your team through the life of EOM, from strategic planning, implementation, and ongoing program refinement. A Clinical Practice Transformation Advisor, will design an implementation plan with you tailored to your organizational objectives, and will help you continuously analyze your performance data for continuous practice improvement to maximize quarterly performance outcomes.

Return on Investment: Using Carevive Versus Doing It Yourself (DIY)

Our clients estimate that Carevive has created efficiencies resulting in them spending half of what it would cost them if implementing the practice transformation on their own. Request a proposal so we can prepare a personalized ROI for your cancer program based on the make-up of your clinical care team, patient population, and practice patterns/preferences.

Request a proposal

Related EOM Videos

What advice do you have for other administrators participating?

Are you working with other major commercial payer customers on value-based programs?

Are you going to participate in EOM? If not sure, why?

Peer-to-Peer Discussions: August 10th, 2022 Live Webinar

How Does Carevive Align With FFS and Value-Based Reimbursement In The Future?

ASCO Quality: Rapid Reaction

The Enhancing Oncology Model with Madelyn Herzfeld

Peer-to-Peer Discussions: August 26th, 2022 Live Webinar

ePROs Implementation Chat with Dr. Ethan Basch

Related EOM Poster Presentations

Poster: Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status

Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status

| Posters, Resources | No Comments
This study demonstrates the feasibility of gathering PROs with real-world data among a cohort of patients with AML using a remote symptom monitoring platform, across baseline prognostic and therapeutic factors.
Poster: Beliefs, Goals, Preferences, and Top Concerns of Patients with Acute Myeloid Leukemia at a Treatment Decision Visit

Beliefs, Goals, Preferences, and Top Concerns of Patients with Acute Myeloid Leukemia at a Treatment Decision Visit

| Posters, Resources | No Comments
The aim of this study was to determine feasibility of patients using a touchscreen computer to record goals, preferences and top concerns to share with the physician at a treatment decision visit.
Poster: Evaluation Of Treatment Choices At Baseline Among Breast Cancer Patients Based On The Frailty Status Of The Patients

Evaluation Of Treatment Choices At Baseline Among Breast Cancer Patients Based On The Frailty Status Of The Patients

| Posters, Resources | No Comments
Previous studies have shown that frailty scores aid in better patient assessment and in advising treatment strategies for Acute Myeloid Leukemia (AML) (Jamy, et al., 2021), and Multiple Myeloma (Nathwani, et al., 2017, 2019). This study aims to evaluate the impact of frailty status on treatment choices among breast cancer patients.
Poster: Patient-Reported Symptom Burden in Women Undergoing Treatment for Early-Stage and Metastatic Breast Cancer

Patient-Reported Symptom Burden in Women Undergoing Treatment for Early-Stage and Metastatic Breast Cancer

| Posters, Resources | No Comments
Women undergoing treatment for breast cancer experience both disease- and treatment-related symptoms. Remote symptom management (RSM) programs allow real-time symptom documentation, earlier intervention, and opportunities to improve quality of life and decrease symptom burden. Prior studies have focused on the supportive care needs of women with advanced breast cancer.

Request Proposal